Purified recombinant Human Osteoprotegerin protein Expression System: E.coli Bioactivity: Determined by its ability to neutralize the stimulation of U937 cells treated with 10 ng/mL of soluble RANKL (sRANKL).
Crystallography grade
TNFRSF11B
Spezies: Human
Wirt: Insektenzellen
Recombinant
>95 % as determined by SDS PAGE, Size Exclusion Chromatography and Western Blot.
SDS, WB, ELISA, Crys
Osteoprotegerin (OPG) is a member of the TNFR superfamily that can act as a decoy receptor for RANKL. Binding of soluble OPG to sRANKL inhibits osteoclastogenesis by interrupting the signaling between stromal cells and osteoclastic progenitor cells, thereby leading to excess accumulation of bone and cartilage. OPG is expressed in a wide variety of tissues including adult heart, lung, kidney, liver, spleen, prostate, lymph node and bone marrow. OPG is secreted both as a monomeric and a dimeric protein. Its primary structure consists of seven distinct domains, four of which corresponds to the extracellular cysteine-rich domains of TNFR proteins and constitutes the soluble OPG. Alternative Names: osteoclastogenesis inhibitory factor protein, TNFRSF11B protein, OCIF protein, OPG protein, TR1 protein